Bill
Bill > S696
summary
Introduced
01/22/2019
01/22/2019
In Committee
07/23/2020
07/23/2020
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
191st General Court
Bill Summary
For legislation to promote transparency and cost control of pharmaceutical drug prices. Health Care Financing.
AI Summary
This bill aims to promote transparency and cost control of pharmaceutical drug prices. It requires the Massachusetts Health Policy Commission to develop a list of "critical prescription drugs" and compel drug manufacturers to report detailed information about the costs of production, research and development, marketing, and pricing. The bill also directs the Commission to analyze the impact of discounts, rebates, and other financial assistance programs on healthcare costs and utilization. The goal is to better understand drug pricing and its effect on the state's healthcare cost growth, with the potential to recommend actions to lower drug costs while maintaining access to high-quality care.
Committee Categories
Health and Social Services
Sponsors (3)
Last Action
Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session (on 07/23/2020)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://malegislature.gov/Bills/191/S696 |
| Bill | https://malegislature.gov/Bills/191/S696.pdf |
Loading...